Director/PDMR Shareholding

RNS Number : 3147C
Epistem Holdings plc
15 October 2015
 



 

 

 

 

 

Epistem Holdings Plc ("Epistem" or the "Company")

 

Directors' Shareholdings

 

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.

 

As a result of the subscription for Partnership Shares and the award of Matching Shares, executive Directors, Dr Catherine Booth, John Rylands & Dr Allan Brown and Matthew Walls each increased their beneficial interests in the Company by 951 ordinary shares of 1.5p each. These shares were acquired on 28 April 2015, 28 May 2015, 26 June 2015, 28 July 2015, 28 August 2015 and 28 September 2015 at prices of 317p, 285p, 275p, 240p, 193p and 180p respectively.

               

Following these transactions, the current beneficial interests of the executive Directors are set out below:

 

                                                                Ordinary Shares                  %

 

Dr Catherine Booth                             988,126                                 9.35%

John Rylands                                        198,024                                 1.87%

Matthew Walls                                      13,771                                 0.13%

Dr Allan Brown                                         2,712                                 0.03%

 

 

 

 

For further details please contact:

 

Epistem Holdings Plc

Dr Ian Gilham: Chairman                                                                                  ++44 (0)161 606 7258

John Rylands: Finance Director

 

Peel Hunt LLP

James Steel                                                                                                           ++44 (0)207 418 8900

Oliver Jackson

 

Consilium Strategic Communications

Chris Gardner / Laura Thornton                                                                          +44 (0)203 709 5700

                                                                                                             epistem@consilium-comms.com 

 

 

Please see http://www.epistem.co.uk for additional information.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBCBDGGGBBGUS

Companies

Genedrive (GDR)
UK 100

Latest directors dealings